why choose us

First received: June 04, 2023

Clinical Trial: Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Head and Neck Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

Brief Summary: This phase I trial tests the safety and effectiveness of indium In 111 panitumumab (111In-panitumumab) for identifying the first lymph nodes to which cancer has spread from the primary tumor (sentinel lymph nodes) in patients with head and neck squamous cell carcinoma (HNSCC) undergoing surgery.The most important factor for survival for many cancer types is the presence of cancer that has spread to the lymph nodes (metastasis).Lymph node metastases in patients with head and neck cancer reduce the 5-year survival…

Read more